Learn More
Cayman Chemical LInaglIptIn 100mg

Supplier: Cayman Chemical 23306100 MG
A potent DPP-4 inhibitor (IC50 = 1 nM for human recombinant DPP-4); ≥10,000-fold selectivity for DPP-4 over other a panel of 11 peptidases and proteases; inhibits 90% of plasma DPP-4 activity in rat; dose-dependently decreases plasma glucose and increases plasma levels of GLP-1 and insulin in Zucker diabetic fatty rats; reduces HbA1c levels in mice with high-fat diet- and low-dose streptozotocin-induced diabetes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.